Dougan Brady W's Form 4 filing
Humacyte, Inc. (HUMA) · filed Aug 20, 2025
- Accession no.
- 0001104659-25-081009
- Filed
- Aug 20, 2025
- Trade date
- Aug 18-20, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.73M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dougan Brady WCIK 0001878020 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Common Stock | SSaleDisposed | −549,360 | $1.83 | −$1,005,328.8 | 1,691,685 | Indirect | Duplicate filing |
| Aug 19, 2025 | Common Stock | SSaleDisposed | −1,100,000 | $1.63 | −$1,793,000 | 591,685 | Indirect | Duplicate filing |
| Aug 20, 2025 | Common Stock | SSaleDisposed | −591,685 | $1.58 | −$934,862.3 | 0 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.